MIR4703

Across TCGA pan-cancer cohorts, MIR4703 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated MIR4703 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR4703 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4703 expression acts as an unfavorable survival marker.

STAD, BRCA, and LIHC are the cancer types where MIR4703 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.235	0.576	<.001	114	view →
BRCA	OS	Tertile	III,IV	0.497	0.908	.004	36	view →
LIHC	DFS	Tertile	II,III,IV	0.046	0.427	<.001	36	view →
KIRC	DFS	Tertile	All	0.193	0.631	.006	30	view →
THCA	DFS	Tertile	IV	0.126	0.805	.002	27	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

MIR4703–STAD (DFS)

Open the STAD breakdown →